Shanghai Bio-heart Biological Technology Co., Ltd. (2185.HK)
HKD 2.49
(1.63%)
HKD 2.49
(1.63%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -181.9 Million CNY | 37.97% |
| 2022 | -293.27 Million CNY | 40.6% |
| 2021 | -493.71 Million CNY | -34.14% |
| 2020 | -368.04 Million CNY | -1184.25% |
| 2019 | -28.65 Million HKD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | -15.64 Million HKD | 55.52% |
| 2024 Q2 | -15.51 Million HKD | 0.15% |
| 2023 Q2 | -53.67 Million HKD | 5.52% |
| 2023 FY | -181.9 Million CNY | 37.97% |
| 2023 Q4 | -35.87 Million HKD | -2.57% |
| 2023 Q3 | -34.97 Million HKD | 34.84% |
| 2023 Q1 | -56.81 Million HKD | 20.92% |
| 2022 Q2 | -151.23 Million HKD | 0.0% |
| 2022 FY | -293.27 Million CNY | 40.6% |
| 2022 Q4 | -71.84 Million HKD | -2.58% |
| 2022 Q3 | -70.03 Million HKD | 53.69% |
| 2021 Q4 | -223.46 Million HKD | 0.0% |
| 2021 Q2 | -270 Million HKD | 0.0% |
| 2021 FY | -493.71 Million CNY | -34.14% |
| 2020 FY | -368.04 Million CNY | -1184.25% |
| 2019 FY | -28.65 Million HKD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Uni-Bio Science Group Limited | 67.76 Million HKD | 368.429% |
| CK Life Sciences Int'l., (Holdings) Inc. | 897.95 Million HKD | 120.258% |